Combination immunotherapy helps overcome melanoma treatment resistance

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune ...
Hoodline

University of Cincinnati Cancer Center Announces Breakthrough in Melanoma Treatment with Oncolytic Virus and Immunotherapy Combo

University of Cincinnati reported positive Phase 2 melanoma trial results, with a third of patients responding to a combined ...

Study finds promising first evidence of targeted therapy for NRAS-mutant melanoma

New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...
TipRanks on MSN

Scancell’s iSCIB1+ Shows Promising Results in Melanoma Treatment

The latest update is out from Scancell Holdings ( (GB:SCLP) ).
Labroots

Novel Therapy Developed for Aggressive Melanoma Subtype

Neuroblastoma RAS viral oncogene homolog (NRAS)-mutant melanoma is an aggressive form of skin cancer that develops because of ...

Medicenna and Fondazione Melanoma Onlus Collaborate to Advance MDNA11 Before First-Line Therapy in a Randomized Neoadjuvant Combination Trial, "NEO-CYT", in High-Risk ...

NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, ...
Healio

New treatments worsened income-based survival disparities for lung cancer, melanoma

Treatment innovations in advanced lung cancer and melanoma over the past 2 decades have significantly improved OS, but they ...
News-Medical.Net on MSN

Breakthrough research offers first targeted treatment option for NRAS-mutant melanoma

New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...
News-Medical.Net on MSN

Study reveals how melanoma evolves to resist immunotherapy

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin ...

Promising cancer treatment using LED light and tin flakes kills skin and colon cancer cells in 30 minutes

Researchers at the UT Austin Portugal Program have developed what they say is a remarkable cancer treatment that combines LED ...

CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...